Discovery of 2-(3,4-dialkoxyphenyl)-2-(substituted pyridazin-3-yl)acetonitriles as phosphodiesterase 4 inhibitors with anti-neuroinflammation potential based on three-dimensional quantitative structure-activity relationship study.

MLA

Huang, Chang, et al. “Discovery of 2-(3,4-Dialkoxyphenyl)-2-(Substituted Pyridazin-3-Yl)Acetonitriles as Phosphodiesterase 4 Inhibitors with Anti-Neuroinflammation Potential Based on Three-Dimensional Quantitative Structure-Activity Relationship Study.” Chemical Biology & Drug Design, vol. 93, no. 4, Apr. 2019, pp. 484–502. EBSCOhost, https://doi.org/10.1111/cbdd.13438.

APA

Huang, C., Zhong, Q.-P., Tang, L., Wang, H.-T., Xu, J.-P., & Zhou, Z.-Z. (2019). Discovery of 2-(3,4-dialkoxyphenyl)-2-(substituted pyridazin-3-yl)acetonitriles as phosphodiesterase 4 inhibitors with anti-neuroinflammation potential based on three-dimensional quantitative structure-activity relationship study. Chemical Biology & Drug Design, 93(4), 484–502. https://doi.org/10.1111/cbdd.13438

Chicago

Huang, Chang, Qiu-Ping Zhong, Lv Tang, Hai-Tao Wang, Jiang-Ping Xu, and Zhong-Zhen Zhou. 2019. “Discovery of 2-(3,4-Dialkoxyphenyl)-2-(Substituted Pyridazin-3-Yl)Acetonitriles as Phosphodiesterase 4 Inhibitors with Anti-Neuroinflammation Potential Based on Three-Dimensional Quantitative Structure-Activity Relationship Study.” Chemical Biology & Drug Design 93 (4): 484–502. doi:10.1111/cbdd.13438.